Antimicrobial resistance - why do we have it and what can we do about it?

Author： Dougherty T.J.   Pucci M.J.   Bronson J.J.   Davison D.B.   Barrett J.F.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.8, 2000-08, pp. : 1707-1709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

We All Make Mistakes‐But What Can We Do About It?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 4, 2002-12 ,pp. : 261-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention and Pharmacovigilance: What Should We Do, What Can We Do?

By Edwards I. Ralph  

Drug Safety, Vol. 35, Iss. 2, 2012-02 ,pp. : 87-90

Adis International

Access to resources Recommend Favorite

Dilemmas about the toxicological consequences of metal-on-metal hip prostheses - What we do and do not know, and what we should do?

By Brent Jeffrey  

Clinical Toxicology, Vol. 51, Iss. 4, 2013-05 ,pp. : 195-198

Informa Healthcare

Access to resources Recommend Favorite

What do we know about the entry of Neisseria meningitidis into the meninges?

By Nassif X.   Pujol C.   Tinsley C.   Morand P.   Eugene E.   Marceau M.   Perrin A.   Pron B.   Taha M.-K.  

European Journal of Medicinal Chemistry, Vol. 95, Iss. 4, 1997-10 ,pp. : 219-235

Elsevier

Access to resources Recommend Favorite

Ten years on: what do we know about the Gulf War syndrome?

By Wessely Simon  

Clinical Medicine, Vol. 1, Iss. 1, 2001-01 ,pp. : 28-37

Royal College Of Physicians

Access to resources Recommend Favorite